UBE Corporation
↗Tokyo, Japan
UBE Corporation is a major Japanese multinational chemical company that operates a significant Pharmaceutical Division. The company focuses on two primary pillars in the life sciences sector: proprietary drug discovery and Contract Development and Manufacturing Organization (CDMO) services. UBE's pharmaceutical business specializes in small molecule synthesis, leveraging its historical expertise in organic chemistry to develop treatments for cardiovascular, renal, and inflammatory diseases.
In addition to its own R&D pipeline, UBE is a key partner for global pharma giants, having co-developed blockbuster drugs like Effient (Prasugrel) with Daiichi Sankyo. The company operates manufacturing facilities that are cGMP compliant and inspected by the FDA, PMDA, and EMA, providing high-quality APIs and intermediates to the global market.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Small Molecule Drug Discovery & CDMO
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$3B-$5B
Founded:1897
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:The Master Trust Bank of Japan, Custody Bank of Japan
STOCK
Exchange:TYO
Ticker:4208
Market Cap:$1.8B
PIPELINE
Stage:Commercial
Lead Drug Stage:Approved
Modalities:Small molecule, API Manufacturing
Active Trials:4
Trial Phases:Phase 1: 1 | Phase 2: 1 | Phase 4: 2
FDA Approvals:3
EMA Approvals:2
CORPORATE STRUCTURE
Parent Company:UBE Corporation
Subsidiaries:UBE Corporation Europe, UBE France SAS, UBE Pharma
Key Partnerships:Daiichi Sankyo (Co-development of Prasugrel), Mitsubishi Tanabe Pharma (Marketing of Talion), Eli Lilly (Marketing partner for Effient)
COMPETITION
Position:Niche Player
Competitors:Sumitomo Chemical, Mitsui Chemicals, Mitsubishi Chemical, Lonza (CDMO competitor), Catalent (CDMO competitor)
LEADERSHIP
Key Executives:
Yuzuru Yamamoto - President and CEO
Masato Izumihara - Director and Senior Executive Officer
Scientific Founders:Sukesaku Watanabe
Board Members:Yuzuru Yamamoto, Masato Izumihara, Takanori Funahashi
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of UBE Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with UBE Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.